595
Participants
Start Date
December 31, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
October 31, 2008
Desvenlafaxine succinate sustained-release (DVS SR)
flexible dose of DVS 50-100 or 200 mg every day during 56 days. Extension until 6 months.
Escitalopram
Flexible dose of Escitalopram 10 or 20 mg every day during 56 days. Extension until 6 months.
Buenos Aires
Buenos Aires
Buenos Aires
Buenos Aires
Buenos Aires
Buenos Aires
Buenos Aires
La Plata
Mendoza
New York
New York
Elmsford
Hollis
Syracuse
Pittsburgh
Pittsburgh
Philadelphia
Baltimore
Charlottesville
Richmond
Morgantown
Raleigh
Columbia
Charleston
Mt. Pleasant
Roswell
Atlanta
Gainesville
Maitland
Coral Springs
Fort Myers
Brooksville
Memphis
Middleton
Saint Paul
Northfield
Oak Brook
Overland Park
Wichita
New Orleans
Shreveport
Oklahoma City
Dallas
Denton
Houston
Bellaire
Denver
Peoria
Las Vegas
Pasadena
San Diego
San Diego
Cromwell
Farmington
Waterbury
Boston
Fall River
Piscataway
East Providence
Lincoln
Burlington
Santiago
Barranquilla
Bogotá
Bucamaranga
Mexico City
Monterrey
Tobasco
Chiclayo
Lima
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY